ds-8500a
Small moleculeexperimental
Clinical trial activity
8 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2014 (NCT02222350)
Timeline
Indications
Mechanism of action
GPR119 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ds-8500a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02790684 | Phase 1 | Jun 1, 2016 | Daiichi Sankyo |
| NCT02790671 | Phase 1 | May 1, 2016 | Daiichi Sankyo |
| NCT02647320 | Phase 2 | Jan 1, 2016 | Daiichi Sankyo |
| NCT02669732 | N/A | Jan 1, 2016 | Daiichi Sankyo, Juntendo University |
| NCT02685345 | Phase 2 | Jan 1, 2016 | Daiichi Sankyo, Mediscience Planning, Inc., Yokohama City University |
| NCT02628392 | N/A | Nov 1, 2015 | Daiichi Sankyo |
| NCT03699774 | Phase 1 | May 12, 2015 | Daiichi Sankyo |
| NCT02222350 | Phase 2 | Jul 1, 2014 | Daiichi Sankyo |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Daiichi Sankyo | For profit | 8 | 8 | 3 | 2014 |
| Juntendo University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Mediscience Planning, Inc. | For profit | 1 | 0 | 1 | 2016 |
| Yokohama City University | Academic/Hospital | 1 | 0 | 1 | 2016 |
4 organizations
Page 1 / 1